
EF24
CAS No. 342808-40-6
EF24( EF-24 | 3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone )
Catalog No. M27874 CAS No. 342808-40-6
EF24 treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 68 | Get Quote |
![]() ![]() |
10MG | 120 | Get Quote |
![]() ![]() |
25MG | 255 | Get Quote |
![]() ![]() |
50MG | 410 | Get Quote |
![]() ![]() |
100MG | 605 | Get Quote |
![]() ![]() |
500MG | 1287 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameEF24
-
NoteResearch use only, not for human use.
-
Brief DescriptionEF24 treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK.
-
DescriptionEF24 treatment increases the levels of activated caspase 3 and 9, and decreases the phosphorylated forms of MEK1 and ERK. EF24 shows potent anti-tumor activity in oral squamous cell carcinoma (OSCC) via deactivation of the MAPK/ERK signaling pathway.
-
In Vitro——
-
In Vivo——
-
SynonymsEF-24 | 3,5-Bis[(2-fluorophenyl)Methylene]-4-piperidinone
-
PathwayApoptosis
-
TargetPERK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number342808-40-6
-
Formula Weight347.79
-
Molecular FormulaC19H16ClF2NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (160.60 mM)
-
SMILESCl.Fc1ccccc1\C=C1/CNC\C(=C/c2ccccc2F)C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang M, et al. A genetically incorporated crosslinker reveals chaperone cooperation in acid resistance. Nat Chem Biol. 2011 Sep 4;7(10):671-7.
molnova catalog



related products
-
4E1rcat
4E1RCat is a dual inhibitor of eIF4E:eIF4G and eIF4E:4E-BP1 interaction, and inhibits the binding of eIF4G to eIF4E with IC50 of 3.2 μM.
-
Jolkinolide B
Jolkinolide B is a bioactive diterpene isolated from the roots of Euphorbia fischeriana Steud. Jolkinolide B induces apoptosis in cancer cells. Jolkinolide B can be used for studies on preventing and treating osteolysis.
-
DNL343
DNL343 is a selective and potent eIF2B activator that crosses the blood-brain barrier and inhibits the assembly of stress granules (SGs) induced by the C9ORF72 dipeptide repeats.